Amarin | AMRN - Assets

Stock Price
14.31
Daily Change
-0.28 -1.92%
Monthly
-2.52%
Yearly
37.20%
Q2 Forecast
13.88

Amarin reported $670.78M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Amarin USD 670.78M 10.96M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
BioCryst Pharmaceuticals USD 514.16M 67.73M Dec/2025
DBV Technologies USD 110.49M 32.93M Sep/2025
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Heron Therapeutics USD 255.88M 6.93M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025